Global Health
add_icon

Global Health

1,444.00
+28.90
(2.04%)
Market Cap
38,824.51 Cr
PE Ratio
68.84
Volume
2,49,344.00
Day High - Low
1,447.00 - 1,410.90
52W High-Low
1,491.00 - 956.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
38,824.51 Cr
EPS
20.71
PE Ratio
68.84
PB Ratio
9.60
Book Value
147.34
EBITDA
918.08
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
14.21
Debt to Equity
0.24
Analyst Rating and Forecast
- By Refinitiv from15 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+86.67 %
+86.67 %
Hold
Hold+13.33 %
+13.33 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Global Health Ltd reports Q1FY27 standalone PAT of ₹1,373.07 million. Board approves ₹970 crore Guwahati hospital expansion to 650 beds and appoints Pradeep Kumar Singh as CDO.
neutral
Global Health Limited's Nomination and Remuneration Committee approved the grant of 20,000 Employee Stock Options under the GHL LTIP 2024 Plan. The options carry an exercise price of ₹1,147 each.
neutral
Global Health management will meet analysts in Noida, Gurugram, and Lucknow from June 24 to June 26, 2026. No unpublished price sensitive information will be shared.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
8,803.50
#1 1,26,580.82
58.69
#1 25,420.10
15.58
#1 2,003
38.41
50.48
1,007.40
98,044.58
67.05
8,536.10
18.82
1,442
4.87
30.46
909.95
68,697.42
64.17
9,178.50
16.93
1,064
2.25
40.91
820.00
42,485.92
197.02
4,643.22
8.32
384
-68.70
49.64
1,444.00
#5 38,824.51
#7 68.84
#6 4,410.27
#6 16.94
#5 584
#8 -1.07
54.31
1,806.50
36,917.78
45.73
7,996.30
#1 43.43
811
5.39
32.93
803.70
33,755.92
172.90
3,930.80
28.16
242
-56.00
48.36
499.40
15,830.13
85.63
2,080.08
18.39
168
#1 44.36
50.04
1,462.30
14,851.00
51.57
1,746.90
11.49
282
16.17
46.99
277.05
11,966.64
#1 40.25
1,679.36
17.77
272
35.27
44.09
Growth Rate
Revenue Growth
16.94 %
Net Income Growth
21.29 %
Cash Flow Change
1.91 %
ROE
-13.62 %
ROCE
-9.67 %
EBITDA Margin (Avg.)
-19.68 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
492
588
593
533
627
695
706
732
795
865
855
836
883
975
960
954
1,051
1,135
1,143
1,196
1,326
Expenses
386
442
448
441
485
523
534
540
595
631
621
629
675
728
706
757
784
868
940
915
1,017
EBITDA
106
146
146
92
142
172
172
192
199
234
234
207
208
247
254
198
267
267
203
281
309
Operating Profit %
21 %
24 %
23 %
15 %
21 %
23 %
23 %
24 %
24 %
25 %
26 %
22 %
22 %
24 %
25 %
19 %
24 %
21 %
16 %
21 %
22 %
Depreciation
31
31
33
35
36
37
39
38
40
43
44
46
47
49
49
49
45
50
61
67
69
Interest
16
17
18
28
19
18
21
21
18
20
18
18
18
16
16
15
14
17
22
27
27
Profit Before Tax
58
98
95
29
87
117
112
133
141
171
172
143
144
181
189
133
208
200
120
187
213
Tax
16
31
25
12
28
31
32
32
39
45
49
16
37
50
46
32
49
41
25
46
56
Net Profit
42
67
70
18
59
86
81
101
102
125
124
127
106
131
143
101
159
158
95
142
157
EPS in ₹
5.13
13.22
2.76
0.69
2.32
3.38
3.08
3.77
3.80
4.66
4.61
4.74
3.96
4.87
5.32
3.77
5.92
5.89
3.54
5.36
5.91

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
1,984
2,430
0
2,694
3,146
4,116
4,304
4,766
5,905
Fixed Assets
1,094
1,194
0
1,616
1,776
2,050
2,236
2,514
3,927
Current Assets
472
489
0
502
812
1,580
1,509
1,533
1,675
Capital Work in Progress
317
666
0
464
439
327
388
533
132
Investments
0
0
0
0
0
0
0
3
79
Other Assets
573
570
0
615
930
1,739
1,681
1,716
0
Total Equity & Liabilities
1,984
2,430
0
2,694
3,146
4,116
4,304
4,766
5,905
Current Liabilities
334
296
0
405
420
573
618
619
627
Non Current Liabilities
432
839
0
907
1,110
1,115
781
760
1,294
Total Equity
1,217
1,296
0
1,382
1,616
2,428
2,906
3,388
3,962
Reserve & Surplus
1,136
1,214
0
1,300
1,565
2,375
2,852
3,333
3,908
Share Capital
81
49
0
50
51
54
54
54
54

Cash Flow

Cash Flow
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-20
3
14
87
-78
50
648
-343
-194
Investing Activities
-126
-241
-69
-249
-87
-239
-421
-342
-441
-721
Operating Activities
213
228
63
166
175
242
311
645
612
624
Financing Activities
-88
-7
9
97
-1
-81
160
346
-514
-97

Share Holding

% Holding
Sept 2021
Oct 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
35.04 %
35.03 %
33.08 %
33.08 %
33.08 %
33.07 %
33.06 %
33.05 %
33.04 %
33.04 %
33.04 %
33.03 %
33.03 %
33.01 %
33.01 %
33.01 %
33.01 %
33.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.69 %
0.00 %
12.09 %
12.94 %
12.20 %
12.47 %
11.76 %
11.54 %
11.40 %
10.53 %
10.15 %
9.46 %
DIIs
0.00 %
0.00 %
7.78 %
12.55 %
12.35 %
10.80 %
10.93 %
9.68 %
10.25 %
10.57 %
11.11 %
10.51 %
11.93 %
12.20 %
12.98 %
14.00 %
14.77 %
16.89 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
25.44 %
6.16 %
5.77 %
6.79 %
6.85 %
6.79 %
7.14 %
6.28 %
6.54 %
6.74 %
6.53 %
6.48 %
6.03 %
5.95 %
5.88 %
5.60 %
Others
64.96 %
64.97 %
33.69 %
48.21 %
48.80 %
49.34 %
38.48 %
50.48 %
37.47 %
37.16 %
37.10 %
37.24 %
36.75 %
36.77 %
36.58 %
36.51 %
36.20 %
35.05 %
No of Share Holders
47
48
2,86,944
1,21,407
1,07,120
1,09,798
1,16,627
1,24,775
1,66,253
1,55,307
1,49,722
1,48,633
1,54,688
1,56,372
1,55,806
1,51,241
1,47,390
1,40,531

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
03 Aug 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
03 Aug 2024 1,306.70 1,209.25
19 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2024 1,191.50 1,113.90
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 1,073.35 1,032.55
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 1,001.20 1,042.50
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,203.60 1,241.80
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 1,355.40 1,339.10
22 Aug 2025 DIVIDEND Dividend
0.50 /share
22 Aug 2025 1,241.80 1,389.30
19 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2025 1,339.10 1,367.70
07 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2025 1,348.70 1,280.70
04 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2026 1,030.00 1,114.00
14 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 May 2026 1,170.20 1,196.00
30 Jul 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jul 2026 1,316.95 1,432.60
14 Aug 2026 DIVIDEND Dividend
0.50 /share
14 Aug 2026 1,196.00 1,410.40

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication6 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 31, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2026
Announcement under Regulation 30 (LODR)-Date of payment of DividendJul 31, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJul 30, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 30, 2026
Announcement under Regulation 30 (LODR)-Meeting UpdatesJul 30, 2026
Fixation Of Records Date For Declaration Of Dividend.Jul 30, 2026
Result For The Quarter Ended June 30 2026Jul 30, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJul 30, 2026
Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulations.Jul 30, 2026
Announcement under Regulation 30 (LODR)-Meeting UpdatesJul 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 24, 2026
Board Meeting Intimation for Schedule Of Board Meeting For The First Quarter Ended June 30 2026 Under Regulation 29 Of Listing Regulations.Jul 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2026
Closure of Trading WindowJun 25, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 24, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 18, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 18, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 18, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2026
Announcement Under Regulation 30 (LODR) - Update On Establishment Of Medical CollegeJun 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 08, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 01, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 15, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 15, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 14, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 14, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 14, 2026
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 14, 2026
Board Meeting Outcome For Intimation Of Audited Financial Results.May 14, 2026
Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulations.May 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 11, 2026
Announcement under Regulation 30 (LODR)-Meeting UpdatesMay 11, 2026
Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 And Recommendation Of Final Dividend.May 06, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Kotak Services Fund Direct-Growth
0.62%
33530
0.62%
0.62%
Invesco India Consumption Fund Direct-Growth
2.60%
-15852
-0.29%
-0.64%
Bandhan Healthcare Fund Direct-Growth
3.61%
12000
0.76%
0.93%
ICICI Prudential Quality Fund Direct-Growth
1.07%
-10000
0.01%
1.07%
Tata Nifty Midcap 150 Index Fund Direct-Growth
0.29%
374
0.02%
0.04%
JioBlackRock Sector Rotation Fund Direct-Growth
0.09%
315
0.03%
0.09%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
0.29%
181
0.01%
0.04%
Zerodha Life Cycle Fund 2041 Direct-Growth
0.11%
110
0.11%
0.11%
Zerodha Life Cycle Fund 2036 Direct-Growth
0.08%
90
0.08%
0.08%
Zerodha Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.10%
-55
0.00%
0.02%
Kotak Nifty Midcap 150 Index Fund Direct-Growth
0.29%
41
0.01%
0.04%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.10%
26
0.00%
0.01%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.14%
22
0.01%
0.02%
UTI Nifty500 Shariah Index Fund Direct-Growth
0.20%
-11
0.00%
0.03%
Groww Nifty Midcap 150 Index Fund Direct-Growth
0.29%
-11
0.01%
0.04%
DSP Nifty Midcap 150 Index Fund Direct-Growth
0.29%
11
0.01%
0.04%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.06%
-4
0.01%
0.01%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.19%
-1
0.01%
0.02%
DSP Nifty 500 Index Fund Direct-Growth
0.06%
1
0.00%
0.01%
Invesco India Multicap Fund Direct-Growth
1.37%
0
0.00%
-0.54%
Bandhan Midcap Fund Direct-Growth
0.27%
0
0.00%
0.27%
Canara Robeco Small Cap Fund Direct-Growth
1.68%
0
0.00%
0.17%
Canara Robeco Value Fund Direct-Growth
1.02%
0
0.00%
-0.09%
Canara Robeco Mid Cap Fund Direct-Growth
2.65%
0
0.00%
0.10%
Canara Robeco Large and Mid Cap Fund Direct-Growth
0.93%
0
0.00%
-0.04%

Technical Indicators

RSI(14)
Neutral
54.31
ATR(14)
Less Volatile
42.62
STOCH(9,6)
Neutral
48.85
STOCH RSI(14)
Oversold
16.56
MACD(12,26)
Bearish
-6.23
ADX(14)
Weak Trend
22.89
UO(9)
Bearish
45.85
ROC(12)
Downtrend But Slowing Down
-0.09
WillR(14)
Neutral
-48.59

About Global Health

Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over...more
Listing Date
16 Nov, 2022(3 Years, 9 Months, 2 Days)
Chairperson NameNaresh Kumar Trehan